Skip to Main Content

Contribute Try STAT+ Today

Valeant Pharmaceuticals

Most Read

Humira injection

Pharmalot By Ed Silverman

U.S. International Trade Commission will investigate AbbVie claims that rival stole secrets

The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: Janet Woodcock on Covid antibodies, vaccines for kids, and responding to Omicron

Health By Lev Facher

Some Americans are hesitant about Covid vaccines. But they’re all-in on unproven treatments

Uber headquarters

Health Tech By Mario Aguilar and Mohana Ravindranath

Uber Health’s new chief medical officer wants to sharpen its message

Pharmalot By Ed Silverman

Pharmalittle: Biden administration used hospital funds to buy Covid vaccines and drugs; a cancer drug may help combat HIV

First Opinion By Hedy S. Wald, Herwig Czech and Shmuel P. Reis

Doctors were complicit in Holocaust atrocities. Current and future health care workers need to know that

Opinions+ By James Biggins

Med tech companies that approach value-based care contracting wisely can earn first-mover advantage

Evusheld illustration

Health By Eric Boodman

Patchwork system for rationing a Covid drug sends immunocompromised patients on a ‘Hunger Games hunt’

All Coverage

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Valeant sued by Sprout investors over female libido pill

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Valeant looks to sell Salix to lessen debt load

advertisement

Valeant

Pharmalot By Ed Silverman

Former Valeant CEO and CFO are being investigated by the feds

Pharmalot By Ed Silverman

Congressman calls for probe into Valeant’s pricing of lead poisoning drug

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Pfizer will sell a biosimilar version of Remicade next month

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Drug makers are making huge bets on some cancer meds

Valeant

Pharmalot By Ed Silverman

Huge Valeant price hike on lead poisoning drug sparks anger

Medicine

Pharmalot By Ed Silverman

Rising drug prices are making hospitals feel ill

Hires -- up and down the ladder

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Valeant

Pharmalot By Ed Silverman

Valeant avoids double-digit price hikes with 9.9 percent increases

Hires -- up and down the ladder

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Pfizer pays $14 billion for Medivation and its prostate cancer drug

Valeant Addyi

Pharmalot By Ed Silverman

Valeant gets poor grades for its Addyi female libido pill

Hires -- up and down the ladder

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Valeant under criminal investigation for defrauding insurers

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Valeant reorganizes and maintains earnings forecast

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Valeant overhauls part of its management team

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Valeant losing a crucial revenue tool

Rising drug cost

The Pharmalot View By Ed Silverman

Pharma trade group says price gougers are outliers, but then accepts two more

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: FDA overlooks troubles at Chinese supplier to avoid shortages

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Novartis stops making TB drugs in Pakistan, prompting fear of a health crisis

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: FDA reviewers say Valeant drug carries suicide risks

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Medivation to start takeover talks with Sanofi and others

Hires -- up and down the ladder

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: India inspects 200 drug makers for poor-quality meds